Leuprorelin EP Impurity J arises from subtle synthetic or oxidative modifications within the leuprorelin backbone. Structural variance impacts retention behavior and peptide conformation. Researchers employ it to refine impurity methods and stability guidance. Applications include analytical validation, impurity profiling, and synthetic-route optimization.
CAT No: Z10-101-173
Synonyms/Alias:[8-[5-N-[Imino(1H-pyrazol-1-yl)methyl]-L-ornithine]]leuprorelin; Leuprorelin Impurity J; (2S)-1-((3S,6S,9S,12S,15R,18S)-3-((1H-imidazol-4-yl)methyl)-6-((1H-indol-3-yl)methyl)-21-(3-(1H-pyrazole-1-carboximidamido)propyl)-12-(4-hydroxybenzyl)-9-(hydroxymethyl)-15,18-diisobutyl-1,4,7,10,13,16,19-heptaoxo-1-((S)-5-oxopyrrolidin-2-yl)-2,5,8,11,14,17,20-heptaazadocosan-22-oyl)-N-ethylpyrrolidine-2-carboxamide
Leuprorelin (Leuprolide) EP Impurity J is a synthetic peptide impurity associated with the manufacturing and quality assessment of leuprorelin, a well-known gonadotropin-releasing hormone (GnRH) analog. Structurally, it represents a specific byproduct or degradation product that may arise during the synthesis, storage, or handling of leuprorelin active pharmaceutical ingredient (API). As an identified impurity under the European Pharmacopoeia (EP) guidelines, its presence and quantification are critical for ensuring the purity and safety profiles of peptide-based therapeutics. In research and industry settings, this impurity serves as a reference material for analytical method development, process validation, and impurity profiling, thereby supporting rigorous quality control in peptide production.
Analytical Method Development: Leuprorelin-related impurities such as EP Impurity J are essential for developing and validating high-performance liquid chromatography (HPLC), liquid chromatography-mass spectrometry (LC-MS), and capillary electrophoresis methods. By providing a structurally defined standard, Impurity J enables researchers to establish sensitive and specific detection parameters, optimize separation conditions, and accurately quantify trace levels of impurities in peptide formulations. This supports robust analytical workflows for both research and industrial quality assurance laboratories.
Quality Control and Batch Release Testing: In peptide manufacturing, precise quantification of process-related impurities like EP Impurity J is fundamental to batch release and compliance with regulatory expectations. Utilization of this impurity as a reference standard allows analytical teams to verify the impurity profile of leuprorelin batches, monitor consistency across production lots, and ensure that impurity levels remain within acceptable thresholds. Such rigorous quality control practices help mitigate the risk of product variability and contribute to the overall integrity of peptide-based APIs.
Impurity Profiling and Degradation Studies: The availability of EP Impurity J facilitates comprehensive impurity profiling during forced degradation and stability studies of leuprorelin. Researchers employ this impurity to characterize degradation pathways, identify potential risks associated with storage or formulation conditions, and understand the chemical stability of the parent peptide. Insights gained from these studies inform formulation optimization, packaging strategies, and shelf-life determinations for peptide products.
Peptide Synthesis Process Optimization: Synthetic peptide processes often yield related impurities that must be identified and controlled. The use of EP Impurity J as a process marker allows chemists to monitor the efficiency of purification steps, evaluate the impact of process modifications, and troubleshoot synthetic routes. By tracking the formation and removal of this impurity, process development teams can refine synthesis protocols, enhance yield, and reduce unwanted byproducts, ultimately improving the overall quality of the final peptide product.
Reference Material for Regulatory Documentation: Accurate identification and quantification of impurities are critical components of regulatory submissions for peptide APIs. EP Impurity J serves as a well-characterized reference material that supports the preparation of impurity specifications, validation reports, and other documentation required for regulatory filings. Its use ensures that the impurity profile of leuprorelin meets international standards, facilitating smooth review processes and supporting the global supply of high-quality peptide materials for research and industrial applications.
1. Emu oil in combination with other active ingredients for treating skin imperfections
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
3. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More